![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/PGHL.png)
Share the post "PROCTER & GAMBLE HEALTH LIMITE’s Q3 2024-25 Latest News: Profit Rises by 26.13% YoY"
Highlights
🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company’s sales declined by -0.06 % over the year, decrease in net sales/revenue by -1.16 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -23.55 %, Marginal increase in other income during this quarter, up by 20.73%. 🔹 Profit over the Year and quarter: Significant improvement in profitability for PROCTER & GAMBLE HEALTH LIMITE. Notable increase of 26.13 % in net profit Year to Year, PROCTER & GAMBLE HEALTH LIMITE’s profitability increased by 10.41 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 26.18 % Year to Year. EPS increased by 10.4 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 309.97 Cr | Rs. 313.41 Cr | Rs. 309.77 Cr | -1.16 % | -0.06 % |
| Expenses | Rs. 208.32 Cr | Rs. 199.37 Cr | Rs. 186.34 Cr | -6.54 % | -10.55 % |
| Operating Profit | Rs. 101.65 Cr | Rs. 114.04 Cr | Rs. 123.43 Cr | + 8.23 % | + 21.43 % |
| OPM % | 32.79 % | 36.39 % | 39.85 % | + 3.46 % | + 7.06 % |
| Other Income | Rs. 5.18 Cr | Rs. 3.28 Cr | Rs. 3.96 Cr | + 20.73 % | -23.55 % |
| Interest | Rs. 0.19 Cr | Rs. 0.15 Cr | Rs. 0.15 Cr | + 0 % | -21.05 % |
| Depreciation | Rs. 6.92 Cr | Rs. 5.77 Cr | Rs. 5.55 Cr | -3.81 % | -19.8 % |
| Profit before tax | Rs. 99.72 Cr | Rs. 111.4 Cr | Rs. 121.69 Cr | + 9.24 % | + 22.03 % |
| Tax % | 27.73 % | 26.1 % | 25.3 % | -0.8 % | -2.43 % |
| Net Profit | Rs. 72.07 Cr | Rs. 82.33 Cr | Rs. 90.9 Cr | + 10.41 % | + 26.13 % |
| EPS in Rs | Rs. 43.4 | Rs. 49.6 | Rs. 54.76 | + 10.4 % | + 26.18 % |
Today, we’re looking at PROCTER & GAMBLE HEALTH LIMITE’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a significant year-over-year sales decline of -0.06 %. However, it did see a marginal slip of -1.16 % from the previous quarter. Expenses decreased slightly by -6.54 % quarter-on-quarter, aligning with the annual decline of -10.55 %. Operating profit, while up 21.43 % compared to last year, faced a quarter-on-quarter increase of 8.23 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 7.06 %, but an expansion of 3.46 % sequentially. Other income rose by 20.73 % compared to the last quarter, despite an annual decline of -23.55 %. Interest expenses surged remarkably by 0 % from the previous quarter, yet the year-over-year decrease remains at a moderate -21.05 %. Depreciation costs fell by -3.81 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -19.8 %. Profit before tax grew annually by 22.03 % but saw an increase from the preceding quarter by 9.24 %.
Tax expenses as a percentage of profits decreased slightly by -2.43 % compared to last year, with a more notable quarter-on-quarter decrease of -0.8 %. Net profit rose by 26.13 % year-on-year but experienced a 10.41 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 26.18 % but a quarterly rise of 10.4 %. In summary, PROCTER & GAMBLE HEALTH LIMITE’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 309.97 Cr | Rs. 313.41 Cr | Rs. 309.77 Cr | -1.16 % | -0.06 % |
| Expenses | Rs. 208.32 Cr | Rs. 199.37 Cr | Rs. 186.34 Cr | -6.54 % | -10.55 % |
| Operating Profit | Rs. 101.65 Cr | Rs. 114.04 Cr | Rs. 123.43 Cr | + 8.23 % | + 21.43 % |
| Net Profit | Rs. 72.07 Cr | Rs. 82.33 Cr | Rs. 90.9 Cr | + 10.41 % | + 26.13 % |
| EPS in Rs | Rs. 43.4 | Rs. 49.6 | Rs. 54.76 | + 10.4 % | + 26.18 % |
In reviewing PROCTER & GAMBLE HEALTH LIMITE’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -0.06 % year-on-year, although there was a slight dip of -1.16 % from the previous quarter. Expenses decreased by -10.55 % compared to the previous year, with a decrease of -6.54 % quarter-on-quarter. Operating Profit surged by 21.43 % annually, and saw a 8.23 % increase from the last quarter.
Net Profit showed yearly increase of 26.13 %, and experienced a 10.41 % increase from the previous quarter. Earnings Per Share (EPS) rose by 26.18 % annually, however rose by 10.4 % compared to the last quarter. In essence, while PROCTER & GAMBLE HEALTH LIMITE exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
